Home Newsfeeds EF Hutton Reiterates Buy on Tetra Technologies, Maintains $9 Price Target

EF Hutton Reiterates Buy on Tetra Technologies, Maintains $9 Price Target

EF Hutton analyst Tim Moore reiterates Tetra Technologies (NYSE:TTI) with a Buy and maintains $9 price target.

byBenzinga Newsdesk

January 24, 2023

1 minute read

EF Hutton analyst Tim Moore reiterates Tetra Technologies (NYSE:TTI) with a Buy and maintains $9 price target.

What’s Going On With Verizon and AT&T Stocks Tuesday?

By Anusuya Lahiri

August 29, 1:50 PM

Verizon Communications Inc (NYSE: VZ) and AT&T Inc (NYSE: T) are trading higher after Citigroup analyst Michael Rollins upgraded the rating on the two stoc

Azul Announces The Results Of Its Mandatory Repurchase Offer To Purchase Up To $55.901M In Aggregate Principal Amount Of Its Outstanding 11.500% Senior Secured Second Out Notes Due 2029

By Happy Mohamed

August 17, 8:45 AM

Azul S.A. ((B3: AZUL4, NYSE:AZUL) ("Azul") today announced the results of the offer to purchase for cash (the "Offer") up to US$55,900,850 in aggregate principal amount (the

AZUL

Shark Tank’s Mark Cuban Believes ‘NFTs Are Still Alive’ — Shows Off 100+ Collection

By Mehab Qureshi

May 29, 11:37 PM

Mark Cuban Believes ‘NFTs Are Still Alive' — Shows Off 100+ Collection 1 reply Billionaire investor and NBA’s Dallas Mavericks owner Mark Cuban on Monday said that "NFTs are still alive" and have a "great foundation of collectors."

$MATIC

Vertex’s Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs

By Vandana Singh

February 6, 3:55 PM

Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.

VRTX

EF Hutton Reiterates Buy on Tetra Technologies, Maintains $9 Price Target

Related Posts

What’s Going On With Verizon and AT&T Stocks Tuesday?

Azul Announces The Results Of Its Mandatory Repurchase Offer To Purchase Up To $55.901M In Aggregate Principal Amount Of Its Outstanding 11.500% Senior Secured Second Out Notes Due 2029

Shark Tank’s Mark Cuban Believes ‘NFTs Are Still Alive’ — Shows Off 100+ Collection

Vertex’s Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs